A Hypothetical Circadian–Endocrine Pathway Linking Melanopsin-Expressing ipRGC Dysfunction in Autoimmune Retinopathy to Sexual Dysfunction

A hypothesis paper proposes that autoimmune retinopathy might damage circadian-regulating retinal cells and thereby impair testosterone and nitric oxide signaling — no data included

Journal: International Ophthalmology | Published: 2026-04-08 | Type: Review / Hypothesis | PMID: 41949765 Authors: Antony Rajan Rithin Jacob (Alte University, Tbilisi, Georgia); Esther A Roshini (University College of Engineering, BIT Campus, Tiruchirappalli, India) Funding/COI: No funding declared. No conflicts of interest declared. Authors disclose use of AI tools for grammar and language editing.

Summary

This is a speculation paper, not a study. The authors chain together existing literature to propose that autoimmune retinopathy (AIR) might damage melanopsin-expressing intrinsically photosensitive retinal ganglion cells (ipRGCs), which project to the suprachiasmatic nucleus, thereby disrupting circadian rhythms and — through testosterone suppression and impaired nitric oxide signaling — contributing to erectile dysfunction. The authors themselves acknowledge that "direct evidence of ipRGC damage in AIR is lacking." No patients were examined, no data were collected, and no hypothesis was tested.

Claims

• AIR may injure ipRGCs through immune-mediated mechanisms (by analogy with glaucoma and diabetic retinopathy, which share some pathological features with AIR)
• ipRGC dysfunction could impair SCN-driven circadian rhythms, reducing melatonin rhythm amplitude and disrupting nocturnal testosterone secretion
• Circadian misalignment has been independently associated with reduced nitric oxide bioavailability, a prerequisite for penile erection
• The proposed pathway is five steps long: AIR → ipRGC damage → SCN dysregulation → endocrine disruption → ED — each link is inferred, none demonstrated in AIR patients

Study Quality

There is no study to evaluate. This is a hypothesis-generating narrative review that synthesizes tangentially related literature from autoimmune disease, circadian biology, and sexual medicine. The authors draw analogies from glaucoma and diabetic retinopathy to argue that AIR could damage ipRGCs, then cite general circadian-endocrine literature to argue disrupted SCN signaling could reduce testosterone and nitric oxide. Each inferential step relies on indirect evidence from entirely different conditions.

The full-text conclusion section is a particular concern: it is generic boilerplate about AIR management ("a high index of suspicion along with early diagnosis and treatment may play a critical role") that does not reference the circadian-ED pathway the paper is ostensibly about. This inconsistency suggests the manuscript may have been assembled from disparate sources rather than constructed as a coherent argument.

Red Flags

• Every link in the proposed causal chain is speculative; the authors admit the key mechanism (ipRGC damage in AIR) has no direct evidence
• Five-step inferential chain with no empirical anchoring in the target population
• Authors are from institutions with limited research infrastructure; no apparent clinical or research access to AIR patients
• AI disclosed as used in writing; published conclusion section does not match the paper's hypothesis
• No funding, no institutional affiliation with ophthalmology or urology specialty centers, no collaborators with clinical AIR experience
• AIR itself is rare, making the proposed ED pathway a hypothesis about a hypothesis in a small and hard-to-study population
• Journal is mid-tier ophthalmology; the topic (sexual medicine) falls outside the journal's core expertise

Strengths

• Correctly identifies that AIR is understudied and that inner retinal involvement is underappreciated
• The circadian-testosterone connection it draws on is real and well-documented in the broader literature
• Clearly frames itself as hypothesis-generating rather than claiming demonstrated findings

Verdict

This paper contributes nothing new to the evidence base on erectile dysfunction, circadian biology, or autoimmune retinopathy — it proposes a multi-step speculative pathway and then calls for the actual research to be done. The methodology is narrative review stitched together from distant fields, the conclusion section reads like it was written for a different paper, and the central premise (that AIR damages ipRGCs) lacks any supporting evidence in AIR patients. Hypothesis papers have legitimate value when they synthesize deep domain expertise and point toward tractable experiments; this one does neither with rigor. Skip it unless you are writing a grant proposal that needs a citation for "circadian disruption as a mechanism of ED."